These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17662488)

  • 21. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
    Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
    Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clopidogrel: who, when, and how?
    Cannon CP
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S27-34. PubMed ID: 17917618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome.
    Ng FH; Wong SY; Lam KF; Chang CM; Lau YK; Chu WM; Wong BC
    Am J Gastroenterol; 2008 Apr; 103(4):865-71. PubMed ID: 18177451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clopidogrel 600-mg double loading dose achieves stronger platelet inhibition than conventional regimens: results from the PREPAIR randomized study.
    L'Allier PL; Ducrocq G; Pranno N; Noble S; Ibrahim R; Grégoire JC; Azzari F; Nozza A; Berry C; Doucet S; Labarthe B; Théroux P; Tardif JC;
    J Am Coll Cardiol; 2008 Mar; 51(11):1066-72. PubMed ID: 18342223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of higher clopidogrel loading and maintenance dose to standard dose on platelet function and outcomes after percutaneous coronary intervention using drug-eluting stents.
    Abuzahra M; Pillai M; Caldera A; Hartley WB; Gonzalez R; Bobek J; Dokainish H; Lakkis N
    Am J Cardiol; 2008 Aug; 102(4):401-3. PubMed ID: 18678295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aprotinin reduces the antiplatelet effect of clopidogrel.
    Lindvall G; Sartipy U; Bjessmo S; Svenarud P; Lindvall B; van der Linden J
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):178-81. PubMed ID: 19477870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study.
    Bonello L; Camoin-Jau L; Arques S; Boyer C; Panagides D; Wittenberg O; Simeoni MC; Barragan P; Dignat-George F; Paganelli F
    J Am Coll Cardiol; 2008 Apr; 51(14):1404-11. PubMed ID: 18387444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment.
    Angiolillo DJ; Costa MA; Shoemaker SB; Desai B; Bernardo E; Suzuki Y; Charlton RK; Zenni MM; Guzman LA; Bass TA
    Am J Cardiol; 2008 Feb; 101(4):440-5. PubMed ID: 18312754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of increased aspirin dose after stenting in association with ClOpidogrel: the FIASCO randomized study.
    Cuisset T; Frere C; Quilici J; Uhry S; Morange PE; Mouret JP; Gaborit B; Bali L; Moro PJ; Lambert M; Bonnet JL
    Thromb Res; 2009 May; 124(1):33-6. PubMed ID: 18990434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial.
    Yong G; Rankin J; Ferguson L; Thom J; French J; Brieger D; Chew DP; Dick R; Eccleston D; Hockings B; Walters D; Whelan A; Eikelboom JW
    Am Heart J; 2009 Jan; 157(1):60.e1-9. PubMed ID: 19081397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial.
    Cannon CP; Husted S; Harrington RA; Scirica BM; Emanuelsson H; Peters G; Storey RF;
    J Am Coll Cardiol; 2007 Nov; 50(19):1844-51. PubMed ID: 17980250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.
    Gilard M; Arnaud B; Cornily JC; Le Gal G; Lacut K; Le Calvez G; Mansourati J; Mottier D; Abgrall JF; Boschat J
    J Am Coll Cardiol; 2008 Jan; 51(3):256-60. PubMed ID: 18206732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet therapy in percutaneous coronary intervention: integration of prasugrel into clinical practice.
    Thomas D; Giugliano RP
    Crit Pathw Cardiol; 2009 Mar; 8(1):12-9. PubMed ID: 19258833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonresponders to clopidogrel therapy among Indian patients undergoing elective/adhoc angioplasty.
    Thomson VS; John B; Pati PK; George OK; George PV; Jose J
    Indian Heart J; 2008; 60(6):543-7. PubMed ID: 19276493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of carotid endarterectomy in patients concurrently on clopidogrel.
    Fleming MD; Stone WM; Scott P; Chapital AB; Fowl RJ; Money SR
    Ann Vasc Surg; 2009; 23(5):612-5. PubMed ID: 19747611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study.
    Angiolillo DJ; Bernardo E; Palazuelos J; Desai B; Weisberg I; Alfonso F; Guzman LA; Hernández-Antolin R; Zenni MZ; Macaya C; Fernandez-Ortiz A; Bass TA
    Thromb Haemost; 2008 Jan; 99(1):161-8. PubMed ID: 18217149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clopidogrel induces an acute hemostatic deficit and increases intra abdominal bleeding in rabbits.
    Lortie E; Girard F; Boudreault D; Ruel M; Mansour S; Blais N; Hardy JF
    Thromb Res; 2009 Apr; 123(6):869-73. PubMed ID: 19128824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
    Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
    Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics of platelet functional recovery following a clopidogrel loading dose in healthy volunteers.
    Price MJ; Teirstein PS
    Am J Cardiol; 2008 Sep; 102(6):790-5. PubMed ID: 18774008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.